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ABSTRACT
The human species is the only natural host of Neisseria meningitidis, an important cause of bacterial
meningitis globally, and, despite its association with devastating diseases, N. meningitidis is a com-
mensal organism found frequently in the respiratory tract of healthy individuals. To date, antibiotic
resistance is relatively uncommon in N. meningitidis isolates but, due to the rapid onset of disease
in susceptible hosts, the mortality rate remains approx. 10%. Additionally, patients who survive
meningococcal disease often endure numerous debilitating sequelae. N. meningitidis strains are
classiﬁed primarily into serogroups based on the type of polysaccharide capsule expressed. In total,
13 serogroups have been described; however, the majority of disease is caused by strains belonging
to one of only ﬁve serogroups. Although vaccines have been developed against some of these, a
universal meningococcal vaccine remains a challenge due to successful immune evasion strategies
of the organism, including mimicry of host structures as well as frequent antigenic variation. N.
meningitidis express a range of virulence factors including capsular polysaccharide, lipopolysacchar-
ide and a number of surface-expressed adhesive proteins. Variation of these surface structures is
necessaryformeningococcitoevadekillingbyhostdefencemechanisms.Nonetheless,adhesionto
host cells and tissues needs to be maintained to enable colonization and ensure bacterial survival in
the niche. The aims of the present review are to provide a brief outline of meningococcal carriage,
disease and burden to society. With this background, we discuss several bacterial strategies that
may enable its survival in the human respiratory tract during colonization and in the blood during
infection. We also examine several known meningococcal adhesion mechanisms and conclude
with a section on the potential processes that may operate in vivo as meningococci progress from
the respiratory niche through the blood to reach the central nervous system.
INTRODUCTION
Neisseria meningitidis is a human-speciﬁc Gram-
negative organism, often diplococcal in form, and is
recognized as the leading cause of bacterial meningitis
globally. The genus Neisseria also includes another
pathogenic species N. gonorrhoeae, the cause of
gonorrhoea, which shares numerous common features
with N. meningitidis. However, the niche preference
(nasopharyngeal compared with urogenital tracts) as well
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as the nature of diseases caused suggests signiﬁcant
differences also exist between these pathogens, borne
out of the identiﬁcation of variations at the genetic level
[1]. One major difference between the two organisms is
the expression of surface polysaccharide capsule which
is absent from N. gonorrhoeae, whereas N. meningitidis
strains commonly express one of several capsule types,
which form the basis of their primary classiﬁcation by
serogroup [2]. Further classiﬁcation of N. meningitidis is
based on major outer-membrane porins into serotypes
and serosubtypes as well as LPS (lipopolysaccharide)
into immunotypes [3]. In addition, MLST (multi-locus
sequence typing) classiﬁes strains into STs (sequence
types) based on variations among seven housekeeping
genes [4].
CARRIAGE AND DISEASE
Globally, meningococcal carriage rates of generally
between 10–35% have been reported for healthy adults
[5,6]. Estimation of carriage is, however, limited by
the swabbing techniques employed. Nonetheless, in
populations with individuals in close contact, such as
university students or military recruits, carriage rates
approaching 100% have been found [2,7]. Compared
with the carriage rate, meningococcal disease is rare,
and disease rates vary in different geographic regions
of the world. What changes the colonization state of
the organism into a disease state is not entirely clear. It
appears that a combination of bacterial virulence factors
andhostsusceptibility,includingage,priorviralinfection,
smoking [2] and genetic polymorphisms (reviewed in
[8]), may ultimately lead to meningococcal disease.
Although 13 meningococcal serogroups have been
described(A,B,C,D,29E,H,I,K,L,Y ,W -135,XandZ),
the majority of disease is caused by organisms expressing
one of ﬁve capsule types namely A, B, C, Y and W-
135 (Table 1). Meningococcal disease in Europe and the
Americas is predominantly caused by serogroups B and
C,whereasinAfricatheprincipalcausesareserogroupsA
and C [9]. Serogroup W-135 causes outbreaks around the
world,withserogroupYgenerallyassociatedwithdisease
in the U.S.A. and Canada [9]. The factors that determine
such geographic variation are also incompletely under-
stood [10]. Through MLST, many meningococcal STs
havebeenidentiﬁedwhichareindependentofserogroup.
Of these, a few are disproportionately associated with
disease relative to their carriage levels and so are termed
hyperinvasive lineages [11].
In keeping with carriage, rates of meningococcal
disease are also variable and range from the sporadic out-
breaksobservedacrossEuropetotheepidemicsobserved
across the African meningitis belt (1 per 100000 to 1000
per 100000 population [9]). In general, mortality occurs
in up to 10% of patients with invasive meningococcal
disease [9]. Mortality rates are dependent on the type and
severity of invasive disease, and are greatest for fulminant
septicaemia (up to 55%) followed by meningitis with
associated septicaemia (up to 25%), and lowest for
meningitis without sepsis (generally <5%) [12]. How-
ever,patientswhosurviveinvasivemeningococcaldisease
often live with a number of physical and mental sequelae,
includingamputationoflimbsanddigits,scarringofskin,
deafness, speech impairment and seizures [13].
PREVENTION AND TREATMENT
Treatment of choice for meningococcal disease is
parenteral administration of β-lactam antibiotics, such
as cephalosporins and penicillins, to which resistance is
rarely reported [14]. Meningococcal disease can progress
rapidly from its onset and ﬁrst symptoms, necessitating
pre-hospital administration of antibiotics which has been
shown to reduce mortality rates in patients with invasive
disease [15].
Preventative measures against several serogroups have
been available for a considerable period in the form of
capsule-based vaccines [16]. However, although puriﬁed
capsular antigens elicit protective antibody responses,
they do not induce long-term memory. To overcome
this deﬁciency, conjugate vaccines have been introduced.
In the U.K., a conjugate vaccine against serogroup C
polysaccharide was ﬁrst licensed in 1999 and has resulted
in a signiﬁcant reduction in disease due to this serogroup
(reviewed by [17]). In the U.S.A., tetravalent conjugate
vaccines covering serogroups A, C, W-135 and Y are
undergoing randomized trials for use in the 11–55-year-
oldagegroup[18].However,whereserogroupBprevails,
polysaccharide-basedvaccineshaveprovedmoredifﬁcult
to generate as this polysaccharide is a poor immunogen
for reasons discussed below. In this case, locally effective
vaccines have been developed, for instance in Cuba,
NorwayandNewZealandbasedonstrain-speciﬁcOMV
(outer-membrane vesicle) preparations and have proved
to be successful in reducing the incidence of local
groupBmeningitisoutbreaks[19–21].Atpresent,several
approaches are being adopted to produce a universal
serogroup B vaccine, including genome-based identiﬁc-
ation of potential novel vaccine antigens [22] and more
traditional approaches to identify the key meningococcal
components required for colonization and disease [23].
These, either individually or in combination, could form
a robust means to control meningococcal infections.
MODELS TO STUDY HOST–PATHOGEN
INTERACTIONS
Animal models have been used in a number of invest-
igations [24,25] and have provided some insights into
disease and vaccine efﬁcacy. However, as meningococcal
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Table 1 Important meningococcal serogroups, capsular structures, operon compositions and geographical prevelance
speciﬁcity for its host involves a number of key host-
speciﬁc events during colonization, including cellular
interactions, iron acquisition and immune evasion, the
relevance of animal studies is limited [9,23]. To overcome
this,somestudies,especiallyoncellularinteractions,have
been conducted using human organ cultures which were
establishedtoexaminetheadherenceofN.meningitidisto
nasopharyngealepithelium,andthebacteriumwasfound
to adhere speciﬁcally to non-ciliated cells [26]. However,
the majority of the studies on N. meningitidis have been
carried out using cultured human cell lines to identify
the molecular components of the bacteria required for
the adhesion, invasion and traversal of human cellular
barriers.
The remainder of the current review is presented
in two sections. The ﬁrst combines some of the main
strategiesofimmuneevasionandmechanismsofbacterial
colonization of the human nasopharynx. The second
section presents an overview of the interactions of the
pathogen with host components described in sequence of
the perceived bacterial progression from its colonization
site, the nasopharynx, through the blood stream and the
BBB (blood–brain barrier) to reach the meninges.
STRATEGIES OF N. MENINGITIDIS
SURVIVAL, COLONIZATION AND INFECTION
Immune evasion by surface modulation
In order to overcome immune detection, meningococci
have evolved several mechanisms to change their surface
components. Structural/antigenic variation of these
molecules is one strategy and can involve allelic exchange
of genes or gene fragments from imported neisserial
DNA. This can occur frequently in N. meningitidis as it
is naturally competent and readily takes up DNA from
its environment. In addition, as its genome contains
multiple copies of certain genes, for example opa and
pil, discussed below, intragenomic recombination also
results in frequent surface structural variation [27,28].
Anothersurfacemodulationoccursviaphasevariation,
a process involving on/off expression of genes, for which
several mechanisms have been reported [27–29]. A de-
tailed review of the mechanisms can be found in [30], and
includeSSM(slippedstrandmispairing)andreversiblein-
sertion of mobile elements. The former involves tracts of
repetitiveDNAsequencesthatoccureitherupstreamofa
gene or within an open reading frame, and, through SSM,
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a loss or gain of individual nucleotides or repeat units can
occur at high frequency. Such changes upstream of a gene
determineitstranscriptionalefﬁciencywherebyaprotein
may be synthesized at various levels or may be totally
absent, as in the case of Opc [31]. However, changes
within a gene may introduce stop codons resulting in a
lackoffulltranslationofthegene.Suchasituationoccurs
inopagenes,multiplecopiesofwhichoccurinpathogenic
Neisseriae [28]. The opa genes code for related, but not
identical, proteins. Switching on and off of distinct genes
independently of each other is therefore equivalent to
antigenic variation in Opa proteins. Antigenic variation
of LPS on the other hand may arise from phase variation
of one or more enzymes involved in the synthesis of the
oligosaccharide chain (Figure 1) by SSM, or by modiﬁca-
tionofLPS,forexamplebytheadditionofsialicacid[32].
Key surface structures involved in host
interactions
Surface glycans
N. meningitidis, when isolated from carriers, may
be capsulate or acapsulate, whereas blood and CSF
(cerebrospinal ﬂuid) isolates are invariably capsulate, as
the capsule aids survival in the blood by rendering bac-
teria resistant to antibody/complement-mediated killing
and inhibiting opsonic and non-opsonic phagocytosis
[5,33–35]. Similarly, certain LPS structures (L3, L7 and
L9) may also help immune evasion and are found more
frequently in blood isolates compared with carriage
isolates; the latter tend to express L1, L8 and L10
LPS immunotypes [36]. In addition, both capsule and
certain immunotypes of LPS can inﬂuence the bacterial
adhesion and invasion events which are discussed below.
Capsule
In meningococci, capsular genes are clustered within a
singlechromosomallocus,cps,dividedintothreeregions.
Region A encodes enzymes for the biosynthesis and
polymerization of the polysaccharide, and regions B
and C carry the genes responsible for its translocation
from the cytoplasm to the cell surface [37].
The capsular polysaccharides of the serogroups B, C,
W-135 and Y contain sialic acid [NANA (5-N-acetyl-
neuramic acid); Table 1], and cps region A of these
serogroups harbours a set of conserved genes siaA, siaB
and siaC. These are responsible for the synthesis of sialic
acid in the form of CMP-NANA, required for incorpor-
ation into the capsular polysaccharide. The fourth gene
inthisregion,siaD,encodesaserogroup-speciﬁcpolysia-
lyltransferaseinvolvedincapsulepolymerization[38,39].
In serogroup A, the locus contains four mannosamine
biosynthesis genes designated mynA–D [40].
The incorporation of sialic acids into the capsule and
LPSenablesbacteriatobecomelessvisibletotheimmune
system, as sialic acids are also commonly present on host
cell surfaces. The most striking mimicry, however, occurs
in serogroup B capsule as this α(2–8)-linked sialic acid
homopolymer is structurally identical with a component
of human NCAM (neural cell-adhesion molecule),
crucial for functional plasticity of the central and
peripheral nervous systems. Such identity is responsible
for the particularly poor immune response generated
against serogroup B capsule by humans [41].
Variation of capsule expression
Genetic similarities in the structures of the capsule loci of
serogropus B, C, W and Y (but not serogroup A) appar-
ently favour horizontal exchange of portions of the cap-
sule biosynthetic operon between different serogroups
resulting in the phenomenon described as capsule
switching [42]. As a consequence, any naturally acquired
and vaccine-induced anti-capsular antibodies become
ineffective in controlling the spread of the pathogen [43].
Capsule switching between serogroups B and C has
reportedly arisen in several geographic areas through
in vivo recombination during co-carriage and, overall,
such events cannot be regarded as uncommon [9].
Capsule gene transfers from Y to B and C to W
serogroups have also been observed [44,45]. This
phenomenon has raised concerns about the immune
pressure that serogroup C vaccination programmes may
apply, leading to potential switching of hyperinvasive
serogroup C strains to B, against which no vaccines
are currently available. Recent studies from Spain and
PortugalfollowingserogroupCvaccinationprogrammes
have reported some capsule switching, but it is unclear
whether the incidence is enhanced by vaccination [46].
It is noteworthy that immunization-associated capsule
switching has not been observed in the U.K. [47].
On/off expression of capsule also occurs and is
controlled via a number of genetic events including SSM
of a poly-cytosine tract present within the siaD gene,
resulting in premature termination of its translation [29].
Another mechanism involves reversible disruption of
the sialic acid biosynthesis gene siaA by the precise
integrationandexcisionofaninsertionsequenceelement,
IS1301[29].Phasevariationofcapsuleinﬂuencesbacterial
interactions with target cells as its absence fully exposes
subcapsular adhesins allowing manifestation of their full
functional efﬁcacy.
LPS
N. meningitidis LPS [also referred to as LOS
(lipo-oligosaccharide)] comprises an inner and outer
oligosaccharide core attached to lipid A. The inner core
of meningococcal LPS consists of the diheptose (HepI
and HepII) attached to lipid A, via one of the two
KDOs (2-keto-3-deoxy-d-manno-2-octulosonic acids).
The outer core is heterogeneous, composed of variable
numbers of sugars extending from HepI, added by
glycosyltransferases encoded by lgt genes (Figure 1) [48].
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Figure 1 Schematic diagram showing structural organization of N. meningitidis LPS and some important determinants of
immunotypes
The membrane-located part of meningococcal LPS comprises lipid A bound to two KDO and two heptose (HepI and HepII) moieties. Extended from the membranea r e
the structurally variable α- and β-chains of LPS. The different immunotypes of LPS are determined by variations both in the HepI α-chain extensions (Glc, Gal,
GlcNAc, Gal and sialic acid) and the HepII β-chain extensions (GlcNAc, PEA and Glc). These arise as a result of phase variation in a number of genes shown and
account for the antigenic variation of meningococcal LPS (see [48] for details). PEA may be added at position 3 or 6 on HepII by two distinct enzymes encoded by
lpt3 and lpt6 [143]. The α-chain structures of the L3, L7 and L8 immunotypes are indicated. LNnT and silaylation: the immunotypes L7/L9, L2/L4/L5 contain identical
α-chains terminating in LNnT (Gal-GlcNAc-Gal-Glc structure bound to HepI) which can be sialylated. The L7 immunotype, found in serogroup B and C isolates, refers
to the immunotype lacking sialic acid, whereas L3 is sialylated. Phase variation of the lgtA gene gives rise to the immunotype L8, which cannot be sialylated [48].
Phase and antigenic variation of LPS
LPS antigenic variation is largely linked to phase
variation of the genes that encode enzymes involved
in the extension of saccharide chains linked to HepI.
Variations in the chain composition dramatically alter
antigenic properties of LPS and form the basis of its
classiﬁcation into different immunotypes (Figure 1) [48].
In addition, SSM of a poly-cytosine tract in the lgtG
gene determines the presence or absence of a glucose
or PEA (phosphoethanolamine) at position 3 of HepII,
which also affects its antigenicity [49]. Phase variation
of one or more of the various LPS biosynthesis genes
enables individual meningococci to display a repertoire
of different LPS structures simultaneously [48].
Lactoneotetraose and LPS sialylation
Several LPS immunotypes (L3, L7 and L9) contain
LNnT (lacto-N-neotetraose), comprised of galactose,
N-acetylglucosamine, galactose and glucose linked to
a HepI [50] (Figure 1). LNnT is found in virulent
strains of meningococci and is an acceptor for sialic acid,
which can be added to its terminal galactose residue by
the product of the lst gene, the α-2,3-sialyltransferase
[51]. In serogroups B, C, W-135 and Y that contain
genes for sialic acid synthesis, endogenously produced
CMP-NANA is used for incorporation into LPS. Other
serogroups acquire sialic acid from exogenous sources,
such as human serum and serous secretions, for this
purpose[52].BothLNnTandsialylatedLPSmimichost-
cell-surface structures [53]. Besides its role in immune
evasion [54], LPS sialylation may allow interaction with
SIGLECs (sialic acid-binding, immunoglobulin-like
lectins) located on myeloid cells [55].
Adhesins and invasins of N. meningitidis
N. meningitidis strains express a number of surface
and secreted proteins that bind to human molecules.
Such proteins include, among others, lactoferrin- and
transferrin-binding proteins that enable meningococci to
acquire iron, a crucial growth factor during colonization
and disease (reviewed in [56]). Neisserial porins, whilst
not considered adhesins, interact with numerous human
cells and proteins. The in vitro-deﬁned properties of
porins could have implications in pathogenesis and
generation of an effective immune response (reviewed
in [57]). N. meningitidis expresses two distinct porins,
PorA (formerly class 1 protein) and PorB (formerly
class 2/3 protein based on molecular mass). Both porins
are β-barrel proteins, which associate into trimers in
the bacterial outer membrane through which small
hydrophilic nutrients diffuse into the cell. Individual
porins vary in molecular mass with PorA (∼46 kDa)
being expressed in all strains of meningococci, but may
vary in its level of expression via an SSM mechanism,
and PorB being expressed as one of two mutually
exclusive forms: PorB2 (∼41 kDa) or PorB3 (∼38 kDa)
[3]. The potential functions of these proteins in bacterial
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Figure 2 Pili of N. meningitidis
(A) Transmission electron micrograph of negatively stained preparations of a meningococcal strain (M. Virji and D.J.P. Ferguson, unpublished work). Bundles of hair-like
pilus ﬁlaments stretch several micrometres from bacterial surfaces (arrows). The scale bar represents 0.5 μm. (B) Schematic diagram indicating the relative cellular
location of the gene products involved in pilus biogenesis. Several of these proteins (PilD, F, M, N, O and P) are implicated in the early stages of pilus synthesis,
others (PilC, G, H, I, J, K, and W) may be necessary for functional maturation of the pilus. The pilus is extruded through the outer-membrane pore formed by PilQ.
The remainder of the proteins play roles in pilus function. For instance, PilF and PilT (both inner-membrane-associated ATPases) appear to have opposing roles in pilus
extension and retraction, and control pilus-associated functions, including twitching motility. PilX has been reported to be involved in bacterial aggregation and could
have a role in colonization through promotion of microcolony formation by N. meningitidis (based on [60]). (C) Ribbon diagram of the three-dimensional structure
of a pilin monomer of strain C311 (M. Virji and A. Hadﬁeld, unpublished work) based on that of N. gonorrhoeae pilin [144]. The asterisk shows the structure and
position of the unusual glycan modiﬁcation (digalactosyl 2,4-diacetamido-2,4,6-trideoxyhexose) of the pilin [69]. Pili are made up of multiple pilin monomers stacked
in a helical array, such that each helical turn is made up of ﬁve monomers (shown in a schematic representation of the ﬁbre cross-section, bottom right).
disseminationarediscussedinthelatterhalfofthepresent
review.
Meningococcaladhesinsthatenablebacteriatolocalize
on speciﬁc host cells can be divided into major and minor
groups.Themajoradhesins,piliandtheopacityproteins,
are expressed in abundance on the bacterial surface and
have been studied for a considerable period. Genome
sequencing has led to the discovery of several other
adhesins, which are expressed normally at low levels
in vitro; these may be up-regulated in vivo, but their
potential roles in pathogenesis remain to be fully deﬁned.
In vitro, several meningococcal adhesive structures have
alsobeenshowntoleadtocellularentryandcantherefore
alsoactasinvasins.Themoleculararchitectureand,where
known,thebindingpropertiesofmeningococcaladhesins
are described below.
The major adhesins
Pili
Pili are hair-like projections and are considered primary
adhesion factors utilized by Gram-negative and Gram-
positive bacterial species [58]. Meningococcal pili belong
to the type 4 pilus family, members of which undergo
rapid extension and retraction and thus impart twitching
motility to bacteria expressing the ﬁbres [59]. Besides
these functions, they are involved in facilitating the
uptake of DNA by bacterial cells [58]. Neisserial
pili are ∼6 nm in diameter and can extend several
micrometres from the bacterial surface. They may also
aggregate laterally to form bundles of pili (Figure 2A).
Numerous genes (Pil C-X and ComP) have been
implicated in the biosynthesis and various functions
of meningococcal pili (Figure 2B) [60]. Although no
structure is available for the meningococcal pilus, a
high-resolution structure of the related gonococcal pilus
ﬁlamenthasbeenreported,employingthree-dimensional
cryo-EM (electron microscopy) reconstruction based on
thecrystalstructureofthepilinsubunit([61];Figure2C).
The pilus shaft is composed of identical pilin (PilE)
subunits arranged in a helical array [61]. Pilin encoded
by the pilE gene undergoes sequence variation by
inter- and intra-genomic recombination with one of
several truncated silent pilin genes (pilS) [27]. The
resultant variations in pilin primary structure inﬂuence
cellular interactions via the ﬁbre [62,63]. A distinct
minor pilus-associated protein, PilC, may also promote
neisserial adhesion to host cells [64]. Recently, PilQ
has been shown to act as an adhesin to target laminin
receptor [65].
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Besides PilE and PilC, potential functions of other
pilin-likeproteinsinpilusbiogenesishavebeendescribed
(Figure 2) [60].
Post-translational modiﬁcations of pili
Neisserial pili have been shown to undergo distinct
and unusual post-translational modiﬁcations. Different
PilE modiﬁcations have been reported at several
serine residues in meningococcal strains, including
glycosylation at position 63 and an α-glycerophosphate
at position 93. However, at position 68, the residue
has been reported to be replaced by phosphate,
PEA or ChoP (phosphorylcholine) [23,66–68]. Pilus
glycosylationwastheﬁrstproteinglycosylationreported
for a bacterial protein [69,70]. Although the roles of
these various modiﬁcations remain unclear, several
studies have implicated O-linked glycans in inﬂuencing
cellular interactions,perhapsviaeffectsonpilus/bacterial
agglutination[69–71].Ithasalsobeensuggestedthatpilin
glycosylation may promote secretion of the soluble (S)
pilin subunits [71]. Secreted pilin, by competing for both
anti-pilus antibodies and host cell receptors, could assist
in the protection of bacteria against immune challenge,
as well as promote spread by preventing further bacterial
adhesion at the original site of colonization.
ChoP occurs as a surface component in many mucosal
pathogens. When present on the bacterial surface it may
be targeted by CRP (C-reactive protein) and anti-ChoP
antibodies leading to bacterial clearance. As such, this
component is of potential importance as a vaccine can-
didate to boost natural immunity. The presence of ChoP
on pathogenic neisserial pili is somewhat unusual in that,
in related bacteria, for example in commensal Neisseria
and Haemophilus inﬂuenzae, ChoP is added to LPS
[72,73]. Although the functional signiﬁcance of neisserial
pilus modiﬁcation with ChoP remains unknown, it may
promote bacterial adhesion through binding to the PAF
(platelet-activating factor) receptor [74,75]. In addition,
ChoP may play a role in niche-speciﬁc immune evasion,
i.e. when expressed, in helping to resist antimicrobial
peptides in the nasopharynx, whereas, when absent, in
decreasing complement activation in the blood [75].
Receptors for pili
Direct interactions of piliated organisms with recombin-
ant CD46, also known as membrane co-factor protein,
have been reported [76]. Additionally, CD46-transgenic
mice have increased meningococcal traversal of the
nasopharyngeal epithelium, which results in increased
septicaemia and meningitis compared with controls [25].
However, other studies using gonococci have suggested
that pilus-mediated binding was not dependent on
cellular CD46 expression levels [64,77]. The related
gonococcal pili have been shown to bind to α1a n dα2
integrins on urethral epithelial cells [78]. It is, therefore,
possible that other factors besides CD46 are involved in
mediating meningococcal pilus interactions with human
cells and tissues.
Opa and Opc
N. meningitidis strains commonly express two types of
outer-membraneproteins,OpaandOpc,whichimpartan
opaque phenotype to agar-grown colonies. Whilst Opc
is only expressed by N. meningitidis, Opa proteins are
expressed by both meningococci and gonococci. Opa
and Opc are similar in size (27–31 kDa) and were initially
knownasClass5proteins.Meningococcalstrainspossess
threetofouropaloci,whereasgonococcipossessinexcess
of ten loci, all of which can be expressed independently
of each other [79,80]. Structurally, the Opa proteins are
made up of eight transmembrane domains, arranged in
a β-barrel, presenting four surface-exposed loops. The
β-barrel constitutes a highly conserved region of these
proteins, whereas three of the four surface loops are
variable between different Opa proteins [81]. No crystal
structure has been determined for the Opa proteins, but
structurally they resemble Neisserial surface protein A
(NspA; Figure 3A) [82].
The genes encoding Opa proteins undergo frequent
phase variation of expression (∼10−3). Such high-phase
variability is due to an SSM of tandem CTCTT repeats
presentwithinallopagenes.Althoughthemajorantigenic
variationresultsfromtheshiftofexpressionfromoneopa
gene to the next, antigenic differences between the Opa
proteins can also arise througha variety ofgenetic events,
for example point mutation, deletion, translocation and
import from other members of the Neisseriaceae. Thus
the expressed Opa type can alter randomly; however,
certainOpatypesmaypredominateinclinicalisolatesap-
parently due to their adhesion/virulence properties [83].
The Opc protein is encoded by a single gene, opcA,
w h i c hi so n l ye x p r e s s e di nN. meningitidis. The structure
of Opc was solved in 2002 and, like Opa proteins, it is
a β-barrel protein but with ﬁve surface-exposed loops
(Figure 3B) [84]. The transcriptional control of Opc
expression occurs through an SSM of a poly-cytosine
tract in the promoter region of opcA [31].
Receptors for the opacity proteins
The majority of meningococcal Opa proteins recognize
one or more members of the CEACAM (carcinoem-
bryonic antigen-related cell-adhesion molecule) family,
a branch of the immunoglobulin superfamily [85,86].
Within this family of receptors, CEACAM1 is the
most widely expressed, and is found on epithelial and
endothelial cells, as well as cells of the immune system
[87]. Other members, such as CEA and CEACAM3 are
restricted to epithelial cells and neutrophils respectively,
whereas CEACAM6 is expressed by both epithelial cells
and granulocytes [87]. Meningococcal Opa proteins have
been shown to bind to all these receptors [88]. However,
the afﬁnity and tropism of Opa proteins for distinct
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Figure 3 Structures of the β-barrel outer-membrane proteins NspA and Opc
(A) The ribbon diagram shown represents an Opa-like eight-stranded β-barrel with four surface-exposed loops. The structure is derived from the co-ordinates of an
Opa-like molecule, NspA [82], and was kindly provided by Professor Leo Brady (Department of Biochemistry, University of Bristol, Bristol, U.K.). The transmembrane
domains are highly conserved between NspA and Opa proteins. However, the ﬂexible surface loops are dissimilar and, in Opa proteins, the ﬁrst loop is semivariable
(SV), whereas the second and third loops are more extensively variable (designated hypervariable: HV1 and HV2). (B) Structure of N. meningitidis Opc protein presented
as a ribbon diagram. Opc is a ten-stranded β-barrel presenting ﬁve largely invariant surface-exposed loops. This Figure was kindly provided by Professor Jeremy
Derrick (Department of Biomolecular Sciences, University of Manchester Institute of Science and Technology, Manchester, U.K.) and is reprinted by permission from
MacMillan Publishers Ltd: Nature Reviews Microbiology [23], copyright (2009) (http://www.nature.com/nrmicro/index.html).
CEACAMs may vary, inﬂuenced by the sequence vari-
ation within the Opa variable loops. Minor variations in
thereceptorstructurealsoinﬂuencebacterialinteractions
with the receptor [88–90]. CEACAMs are involved in a
range of cellular processes and the signalling outcomes
following Opa binding depends on the repertoire of
CEACAM family members present on target cells and
the type of Opa protein expressed. In addition, the level
of CEACAM expression may inﬂuence the outcome of
bacterial interaction. For example, CEACAMs may be
expressed at low levels on target tissues, but are subject
to up-regulation under the inﬂuence of inﬂammatory
cytokines [91,92]. Such increased receptor density has
been shown to increase the strength of bacterial
interaction and leads to increased cellular invasion by
virulent forms of meningococci [93]. Hence increased
CEACAM density resulting from inﬂammation could
be a factor that increases host susceptibility to
meningococcal infection and,thereby, responsiblefor the
temporal association reported between inﬂuenza A viral
infection and meningococcal disease [2].
In addition to CEACAMs, some meningococcal
Opa proteins may also interact with cell-surface-
associated HSPGs (heparan sulfate proteoglycans) [88].
There are two major groups of HSPGs, the GPI
(glycosylphosphatidylinositol)-linked and the trans-
membrane syndecan family. The latter are present
on most epithelial cells, and different Opa-expressing
isolates derived from a single strain have been shown
to bind to human conjunctival epithelial cells in a
heparin-sensitivemanner,presumablyviasyndecans[88].
Tyrosine residues in HV2 (hypervariable 2) of Opa
proteins have been implicated in binding to saccharides,
with differing binding speciﬁcities observed between
distinct Opa types [94].
Opc–host interactions
InitiallymeningococcalOpcwasshowntomediateadhe-
sionandinvasionofhumanendothelialcellsbytheform-
ationofatrimolecularcomplexprimarilyinvolvingserum
vitronectin and, to a lesser extent, ﬁbronectin and their
corresponding integrin receptors [95,96]. More recently
similar observations primarily involving ﬁbronectin and
human brain endothelial cell integrins have also been
reported [97]. Opc is also able to mediate adhesion to
and invasion of epithelial cells in the absence of serum
proteins by binding to HSPGs [98]. Binding to HSPGs
may involve a basic cleft formed by the surface loops
of Opc [84,94]. It has been suggested that Opc requires
heparin to target vitronectin [99]. In addition, recently,
a novel mechanism of vitronectin targeting by Opc has
been identiﬁed requiring the activated unfolded form of
vitronectin, which reveals its otherwise cryptic tyrosine-
sulfated moieties required for Opc interactions (C.S.
Cunha, N.J. Grifﬁths and M. Virji, unpublished work).
This form of vitronectin may be conceivably generated
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during meningococcal sepsis [100]. Availability of an
increasedsupplyofactivatedvitronectintomeningococci
in the blood stream could enhance cellular interactions
at the brain and vascular endothelial interfaces, and
increase the bacterial potential to traverse these cellular
barriers.Whetherthisoccursinvivoremainstobeshown.
Minor adhesins
Several of the novel adhesins more recently identiﬁed be-
longtotheautotransporterfamilyofmolecules(reviewed
in[101]).Ofthese,NadA(NeisserialadhesinA),anOCA
(oligomeric coiled-coil adhesin), was ﬁrst identiﬁed as
a novel vaccine candidate by genome mining and later
shown also to possess adhesive properties. NadA inter-
acts with human epithelial cells through protein–protein
interactions, but the nature of the receptor is unknown
[102]. Although phase variable, NadA may contribute to
bacterial virulence as it is expressed by ∼50% of disease
isolates compared with ∼5% of strains isolated from
healthy individuals [103]. Two other proteins, NhhA
(Neisseria hia homologue A) and App (adhesion and
penetration protein) are widely expressed in virulent N.
meningitidis strains. NhhA mediates low levels of adhe-
sion to epithelial cells, HSPGs and laminin. App, which
may be processed and released, may aid bacterial col-
onization as well as spread [104]. MspA (meningococcal
serineproteaseA)ishomologoustoAppandmayalsobe
cleavedandsecreted.Itisexpressedbyseveral,butnotall,
virulentmeningococcallineagesandmaysupportbinding
tobothepithelialandendothelialcells[105].Noreceptors
have been identiﬁed for either App or MspA to date.
MENINGOCOCCAL PROGRESSION FROM THE
NASOPHARYNX TO THE MENINGES
An overview of meningococcal and host factors that may
be involved at distinct stages of meningococcal–host
interactionsareshowninaschematicforminFigures4–6.
Colonization and penetration of the
respiratory mucosa
During transmission, N. meningitidis is believed to be
encapsulatedwhichmayenhancesurvivaloftheorganism
outside the host [41]. Although one study has demon-
stratedthatencapsulatedN.meningitidishasthepotential
to survive for several days ex vivo [106], it is also possible
that acapsulate organisms can pass from person to person
overshortdistancesandbydirectcontact.Meningococcal
strains carried by asymptomatic individuals in most
non-epidemic situations may be capsulate or acapsulate,
whereas, in epidemic situations, such as those that occur
regularly in the sub-Saharan meningitis belt, carriage of
capsulate phenotypes is more common [107,108].
From in vitro observations, the following potential
interactions may be surmized, but in vivo evidence is
lacking for most presumed events. In considering the
primary events, it would appear reasonable to assume
that a ﬁrm and fast adhesion to mucosal epithelial cells
is essential for the pathogen to avoid being ﬂushed
away by the ﬂow of mucus. The adhesive properties of
capsulate N. meningitidis are primarily mediated by pili
which extend beyond the capsule and initiate binding to
non-ciliated epithelial cells [26,58,63].
Although the capsule promotes bacterial survival by
resisting the environmental and host factors discussed
above, it may adversely affect bacterial ability to colonize
as it can sterically hinder the surface-expressed adhesins
andthuspreventmoreintimatecellularinteractions.Thus
phase variation in capsule expression that may occur
via the genetic mechanisms described above could be
beneﬁcial following initial attachment by pili. Acapsulate
phenotypes arising at this stage can engage more
intimately with cells via the outer-membrane proteins,
includingOpaandOpc,aidingbarrierpenetration.How-
ever, although pili are considered to be primary adhesins
in capsulate phenotypes, under some circumstances,
outer-membrane proteins may also come into play in
fullycapsulatedphenotypes.Asmentionedabove,athigh
levelsofCEACAMexpressioninducedduringinﬂamma-
tion, cellular invasion can occur in an Opa–CEACAM-
dependent manner even in capsulate organisms, a process
that is synergized by pili [93,109]. Thus, in some circum-
stances (such as inﬂammation induced by a prior viral
infection), encapsulated meningococci may penetrate the
epithelium and enter the blood without the need for cap-
sule down-modulation. Opa–CEACAM1 interactions
also promote epithelial cell attachment through up-
regulation of endoglin (CD105) and co-operation with
β1 integrins, thus overcoming potential innate epithelial
shedding mechanisms to remove infected cells [110].
As for Opa proteins, in unencapsulated meningococci,
Opc is able to facilitate adhesion to and invasion
of epithelial and endothelial cells independently of
other adhesins [111]. Following Opc engagement with
endothelial integrins, a number of signalling events
result in the internalization of N. meningitidis [95,96]
and release of the cytokines IL (interleukin)-6 and
IL-8 [112].
In recent studies, Opc was shown to bind to the
cytoskeletal protein α-actinin of both epithelial and
endothelial cells following cellular invasion [113]. Up-
regulationofα-actinininthelatestagesofendothelialcell
infection has also been observed in vitro [114] and raises
the question as to which role this cytoskeletal protein
might play in the course of meningococcal disease.
Besides the possible interactions described above, a
number of the minor adhesins are also likely to support
bacterial colonization and invasion of the mucosal
barriers. However, whether this occurs in concert or
independently of the major adhesins in vivo remains to
be determined.
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Figure 4 Schematic overview of meningococcal interactions at the epithelial barrier of the nasopharynx and the mode of
barrier penetration
Encapsulated (and possibly acapsulate) meningococci inhaled via respiratory droplets must ﬁrst adhere to the epithelium within the nasopharynx to avoid removal
by innate immune mechanisms such as mucus clearance. Pili extending beyond the capsule are considered to mediate the primary interaction with epithelial cells.
Capsule down-modulation (or up-regulation of host receptors during inﬂammatory condition) allows interactions between outer-membrane proteins and their cognate
host receptors. For example, Opa proteins may bind to CEACAMs and HSPGs, and Opc proteins can interact with HSPGs and, via vitronectin and ﬁbronectin, to their
integrin receptors. Although some minor adhesins such as NhhA have been shown to interact with HSPGs, the receptors targeted by MspA, App and NadA remain to
be determined. Engagement of CEACAMs, integrins and HSPGs can result in meningococcal internalization by epithelial cells (1) by triggering a variety of host cell
signalling mechanisms. Meningococci can be found in subepithelial tissue (2) in healthy individuals thus cellular entry or otherwise traversal across the epithelium
may not be an unusual event. In addition, the fact that meningococci can interact with subcellular proteins such as α-actinin may also lend some support to this
notion, although the role of this interaction in vivo remains unclear. On crossing the epithelial barrier, meningococci are able to interact further with proteins of the
extracellular matrix including ﬁbronectin (Fn) and vitronectin (Vn). Internalized bacteria may also migrate back to the apical surface for transmission to a new host
(3). An animated version of the Figure is available at http://www.ClinSci.org/cs/118/0547/cs1180547add.htm.
N. meningitidis is subject to constant selective
pressuresanditsabilitytoadaptrapidlytoenvironmental
challenges is essential for its survival [115]. Phase and
antigenic variation of a number of surface components
permits immune evasion during infection. This also has
thepotentialtogeneratevariantswithanalteredabilityto
colonize and heightened ability to penetrate the mucosal
barriers [86,116]. In addition, the invasive ability of
meningococci could also enable the bacteria to avoid host
immune mechanisms by entering epithelial cells. Indeed,
N. meningitidis has been found in tissues underlying the
mucosal surface in healthy individuals [117]. Whereas,
in an immune host, further dissemination from such a
site would be prevented by active serum bactericidal and
other defences, in a susceptible host any meningococci
traversing the epithelial barrier could survive and spread
via the vasculature.
Haematogenous spread
Within the blood stream, meningococci produce a strong
inﬂammatory response and activate the complement
and the coagulation cascades. A key inducer of cellular
inﬂammatory responses, LPS, is pivotal in causing
meningococcal sepsis [118]. LPS-induced secretion of
various cytokines within the vasculature ultimately leads
to endothelial damage and capillary leakage, leading to
necrosis of peripheral tissues and multiple organ failure
[119]. A relationship between circulating levels of LPS
and mortality rates in meningococcal disease has been
demonstrated [120].
The lipid A moiety of LPS is the active component
responsible for eliciting the inﬂammatory response
associated with meningococcal sepsis. LPS induces the
release of several cytokines, including IL-6 and TNF-α
(tumour necrosis factor-α), as well as chemokines,
ROS (reactive oxygen species) and NO, acting in part
through TLR (Toll-like receptor) 4 [121,122]. Natural
LPS variants lacking a single acyl chain engage less well
with TLR4, yet can cause clinical disease and so may be
better placed to evade the innate immune system [123].
In the blood, N. meningitidis encounters numer-
ous host killing mechanisms, including antibody/
complement-mediated lysis, as well as opsonophagocytic
killing. Disruption of genes associated with capsule and
LPS synthesis results in an increase in meningococcal
sensitivity to serum killing, indicating the importance
of these polysaccharides for survival in the blood [124].
The amount of polysaccharide capsule expressed also
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Figure 5 Meningococcal entry into and survival within the vasculature
Capillaries in close proximity to mucosal epithelial tissues are a possible point of entry into the blood for N. meningitidis. In vivo, meningococci initially encounter the
basolateral surface of endothelial cells and need to traverse in a basal to apical direction to enter the vasculature. The in vitro studies, however, do not allow easy
examination of basal interactions as cultured cells present their apical surfaces to the media. Both integrins and HSPGs are known to be expressed on the basolateral
surface of endothelial cells and, hence, are likely targets for vascular penetration. However, it should be noted that these receptors are also expressed apically and
are also probably involved in the exit from the bloodstream. Once in the blood, only capsulate meningococci appear to survive; whether acapsulate bacteria arising
naturally can survive in any microenvironment is not known. In addition, meningococci are able to bind to a number of negative regulators of complements u c ha s
C4bp, factor H and vitronectin. Acquisition of such factors could lead to decreased complement-mediated killing in vivo. Interactions with vascular cells via protein
adhesins and their cognate receptors and via LPS–TLR4 provoke an inﬂammatory response leading to cytokine release and cellular damage. This could increase further
cell barrier penetration and leakage, which accounts for the damage and clinical symptoms observed during meningococcal sepsis, typiﬁed in latter stages by a
petechial rash (see inset; from meningitis.org). LPS has also been shown to be toxic for human endothelial cells in vitro [40].
appears to inﬂuence meningococcal resistance to host
killing [125].
Negative regulators of complement can be recruited
by meningococci to promote their survival. Factor H is
recruited by fHbp (factor H-binding protein; also named
GNA1870), a 27 kDa lipoprotein which is expressed by
all meningococcal strains and which promotes serum
resistance [126]. The porin PorA of meningococci
can also bind a complement regulator, C4bp
(C4-binding protein), and inﬂuence serum resistance.
However, capsule may inhibit C4bp binding to PorA
[33].
It has been suggested that both PorA and PorB may
be involved in bacterial uptake via re-arrangement of
the cytoskeleton [127]. Porins may also act via TLR2 as
an adjuvant leading to the stimulation of B-cells [128].
It has also been demonstrated that PorB has an anti-
apoptotic effect on epithelial cells, by localizing in the
mitochondrial compartment, enhancing survival of the
cell upon apoptotic stimuli [129]. Porins therefore appear
to have multiple roles in meningococci from aiding not
only colonization, but also survival in the blood.
Besides facilitating entry into the vasculature, some
bacterial adhesins may also function directly in resisting
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Figure 6 Meningococcal penetration of the BBB and interaction with the meninges leading to meningitis
In areas of low blood ﬂow and, hence, low shear stress, meningococci have been shown to adhere to the vasculature within the brain [139]. In addition, cytoskeletal
re-arrangements leading to lipid microdomain formation could facilitate resistance to shearing forces once bacteria are bound [145]. Whether bacterial transmigration
in this niche is predominantly by transcytosis across intact cell barriers or requires damage to the barrier (for example, due to the action of pro-inﬂammatory
cytokines) for ease of passage is unknown, although more than one mechanism may operate. Once the BBB is breached, meningococcal interaction with cells lining
the leptomeninges leads to the release of pro-inﬂammatory cytokines [9,108,142], provoking an inﬂammatory reaction resulting in meningitis.
complement-mediated killing. Vitronectin inhibits the
formation and insertion of a MAC (membrane attack
complex) into bacterial membranes. In binding directly
to vitronectin, Opc-expressing bacteria are able to resist
serum-mediated killing [130]. Thus meningococci have
the means to interact with several regulators of the
complement pathways which could lead to increased
bacterial survival in the blood.
N. meningitidis can bind to and inﬂuence cells within
the vasculature. Peripheral blood mononuclear cells
from individuals immunized with a range of outer-
membrane proteins of N. meningitidis have a higher
proliferative response to Opa than to other neisserial
proteins[131].Anotherstudydemonstratedasuppressive
effect on T-cell activation and proliferation in response
to Opa-containing meningococcal OMV preparations
[132]. However, no such deleterious effects of Opa-
containing OMVs used as vaccines have been reported
[133]. Recent studies have also shown Opa-independent
proliferation of T-cells in the presence of N. meningitidis
[134].ThustheinﬂuenceofOpaproteinsonimmunecells
is unclear and whether the Opa receptor CEACAM1,
which is expressed on stimulated T-cells is involved,
remains to be clariﬁed.
Engagement of CEACAM3 by Opa-expressing N.
gonorrhoeae has been postulated to result in increased
cell death of neutrophils during infection [135]. Such
interactions of N. meningitidis could also lead to evasion
of killing by promotion of neutrophil cell death, but this
remains to be investigated.
Of the minor adhesins, NadA-expressing Escherichia
coli adhere to and activate human monocytes and macro-
phages.Inaddition,puriﬁedNadAinducedhighlevelsof
TNF-α and IL-8 production by these cells [136]. Recent
work has demonstrated that OMVs containing NadA
possessed enhanced immune stimulation compared with
controls, suggesting an additional role for this adhesin in
septic shock ([137] and references therein).
Inconclusion,it is widelybelieved that thekey players
in meningococcal survival in the blood include capsule
and LPS. In addition, proteinaceous adhesins also play
important roles in entry to and exit from the vasculature
and may also modulate immune responses. Notably,
however, perceptible bacteraemia is not required
for meningitis to follow, although the vasculature is
considered the primary route to the brain [138].
Reaching the meninges
Two structures make up the BBB: ﬁrst, the choroid
plexus, located in the ventricles and formed by cuboidal
epithelial cells with tight junctions; and, secondly, the
capillaryendotheliaalsohavingtightjunctions.Adhesion
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in the vasculature is greatly inﬂuenced by the ﬂow rate
and shear stresses imposed on meningococci. On a
post-mortem histological examination of one individual,
meningococci were observed adherent to capillaries
with low rates of cerebral blood ﬂow [139]. Using an
in vitro model in which endothelial cells were subjected
to various shear stresses, the investigators concluded
that pili play a major role in maintaining adherence to
endothelial cells under high ﬂow conditions (although
low shear rates are needed for initial attachment) [139].
Following attachment, a small number of piliated
bacteria are internalized by endothelial cells. These may
transcytose further to enter the meninges. Alternately, it
is possible that signalling in endothelial cells induced by
pili may lead to disruption of the intercellular junctions
enabling meningococcal passage [60]. An alternate
route involves endothelial damage by LPS-mediated
cytopathic effects, a process that has been shown in vitro
to be enhanced by the presence of pili [140].
In addition to pili, other adhesins discussed above may
also function in bacterial adhesion to and penetration
of the BBB. Indeed, in vitro experiments have shown
that meningococci lacking the Opc protein were unable
to traverse human brain microvascular endothelial cell
monolayers [97].
To examine meningococcal interactions within the
CNS (central nervous system), a meningioma model
has been established, representative of cell layers
covering the pia mater and arachnoid membranes
(the leptomeninges) [141]. In capsulate bacteria, pilus
interactionsdominate,yet,inthepresenceofcertainpilus
structures with lowered adhesion capacity, Opa proteins
also mediate adherence of capsulate meningococci to
the meningioma cells [141]. In comparison with N.
lactamica, a commensal species rarely associated with
meningitis, meningococcal adherence to meningioma
cellswashigherandmeningococcicausedgreaterdamage
to the cell monolayers [142]. Increased production of
the cytokines IL-6 and IL-8 and decreased expression
of the chemokine RANTES (regulated upon activation,
normal T-cell expressed and secreted; CCL5) were also
observed in meningioma cells infected with N. meningi-
tidis compared with those infected with N. lactamica
[142]. Species-speciﬁc responses, in terms of cytokine
production and cell damage, point to speciﬁc bacterial
factors and possible host receptors in the inﬂammation
of the meninges. Thus, in common with colonization and
survival in the blood, CNS events resulting in meningitis
are likely to involve dynamic interactions of several
bacterial factors acting in a co-operative manner.
CONCLUSIONS
N.meningitidisencountersanumberofchallengesduring
transmission, colonization and disease development in
humans. These organisms have evolved to colonize hu-
mans speciﬁcally and, in doing so, have acquired a range
of virulence factors to enable survival within their chosen
niche. Normally, meningococci are transient visitors of
the human nasopharynx, but on occasion they can cause
devastating disseminated diseases such as septicaemia
and meningitis in susceptible individuals. The present
review has described a number of surface structures
expressed by N. meningitidis during colonization and
the course of pathogenesis. Several of these structures
are likely to come into play repeatedly during mucosal
colonization haematogenous spread and the inﬁltration
of the meninges. Although considerable advances have
been made in our understanding of meningococcal
disease, the majority of studies (that have been, of
necessity,conductedinvitro)haveexaminedtheimpactof
individual bacterial components on cultured host cells in
isolation; far fewer studies have either examined the co-
ordinate action of multiple meningococcal components
in cell adhesion and invasion or employed whole tissue
models. Host factors, including genetic determinants as
well as lifestyle, inﬂuence an individual’s susceptibility to
meningococcal disease. The full dynamic spectrum of the
bacterial components that may facilitate different stages
of infection, and their interplay and orchestration during
the course of pathogenesis are likely to be considerably
more complicated than we currently understand. There
is still much to unravel about the organism: in particular,
what precisely determines whether it will establish a
commensal or a pathogenic relationship with its only
host.
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